EFFICACY AND SAFETY OF TISAGENLECLEUCEL (TISA‐CEL) IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): PRIMARY ANALYSIS OF THE PHASE 2 ELARA TRIAL. (17th June 2021)

• Record Type: Journal Article
• Authors: Schuster, S. J.; Dickinson, M.; Dreyling, M.; Martinez‐Lopez, J.; Kolstad, A.; Butler, J.; Ghosh, M.; Popplewell, L.; Chavez, J. C.; Bachy, E.; Kato, K.; Harigae, H.; Kersten, M. José; Andreadis, C.; Riedell, P. A.; Abdelhady, A.; Zia, A.; Morisse, M. C.; Fowler, N. H.; Thieblemont, C.
• Is Part Of: Hematological oncology. Volume 39(2021)Supplement 2
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-17
• Subjects: Indolent non‐Hodgkin lymphoma -- Cellular therapies; Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.85_2879
• Languages: English
• ISSNs: 0278-0232